Skip to main content
Clinical Trials/NCT03421262
NCT03421262
Unknown
Not Applicable

Pregnancy Outcomes and Medical Costs According to Gestational Diabetes Mellitus Diagnostic Criteria: Randomized Prospective Study.

Hospital Mutua de Terrassa1 site in 1 country3,644 target enrollmentJune 1, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Gestational Diabetes
Sponsor
Hospital Mutua de Terrassa
Enrollment
3644
Locations
1
Primary Endpoint
Large for gestational age
Last Updated
8 years ago

Overview

Brief Summary

The aim of the study is to evaluate differences in pregnancy outcomes and medical costs depending on gestational diabetes diagnostic criteria used (one vs two-step approach).

Detailed Description

Due to Hyperglycemia and Adverse Pregnancy Outcomes study results, a new gestational diabetes mellitus (GDM) diagnostic criteria was defined using a one-step approach (75-g oral glucose tolerance test -OGTT-). However, not all scientific societies have accepted and have implanted this new diagnostic criteria. The lowest glycemia cut-off of this criteria regarding the two-step approach entails an increase in GDM incidence with discordant studies about its cost-effectivity. It will be assessed if pregnancy outcomes and medical costs are different depending on diagnostic criteria used.

Registry
clinicaltrials.gov
Start Date
June 1, 2017
End Date
December 2019
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Hospital Mutua de Terrassa
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age 18-50 years
  • No expectation that subject will be moving out of the area of the clinical center during the next year
  • Informed Consent Form signed by the subject

Exclusion Criteria

  • Preexisting type 1 or 2 diabetes
  • Advanced HIV( on medications that cause hyperglycemia), severe liver disease, gastric bypass surgery or other illness/surgeries that preclude them from drinking the glucose solution.

Outcomes

Primary Outcomes

Large for gestational age

Time Frame: At birth of infant

Infant birthweight \>90th centile using customized growth curves

Secondary Outcomes

  • Congenital anomalies(At birth of infant)
  • Macrosomia(At birth of infant)
  • Small for gestational age(At birth of infant)
  • Hypertension in pregnant(First 3 months postpartum)
  • Neonatal obstetric trauma(At birth of infant)
  • Neonatal hypoglycemia(up to 4 weeks after delivery)
  • Neonatal hypocalcemia(up to 4 weeks after delivery)
  • Neonatal hyperbilirubinemia(up to 4 weeks after delivery)
  • Neonatal polycythemia(up to 4 weeks after delivery)
  • Respiratory Distress Syndrome(up to 4 weeks after delivery)
  • Infant Outcomes(up to 4 weeks after delivery)
  • Hypertrophic cardiomyopathy(up to 4 weeks after delivery)
  • Polyhydramnios(At birth of infant)
  • Gestational age at delivery(At birth of infant)
  • Cesarean section(At birth of infant)
  • Perinatal mortality(First 7days postpartum)
  • NICU admission(up to 4 weeks after delivery)
  • Maternal hospital stay(up to 4 weeks from maternal discharge)
  • Neonatal hospital stay(up to 4 weeks from neonatal discharge)
  • Evaluation of mediterranean diet adherence(up to 12-14weeks from last menstrual period.)
  • Evaluation of health-related physical activity(up to 12-14weeks from last menstrual period.)
  • Medical cost(First 3 months postpartum)

Study Sites (1)

Loading locations...

Similar Trials